BCL9 and colorectal carcinoma: We also substantiated inhibition of miR‐140‐3p conferred increased proliferation, migration, invasion, and EMT properties to CRC cells, while knockdown BCL9 in miR‐140‐3p inhibitor‐transfected CRC cells blocked these enhancements.